(Total Views: 327)
Posted On: 03/10/2021 10:19:46 AM
Post# of 36568
Well, Generex / NGIO has a 1.5 billion dollar deal with China and we haven't heard anything lately concerning what's going on with it or the rest of the upfront money. That is concerning.
We haven't heard anything on the invoices being paid by Bintai. That is concerning.
We know they are putting in the IND. That will happen within the next 15 days now.
However, that is for the US FDA. What about the China and Malaysia deals? That is 2.5 billion dollars. Let me type that again, 2.5 billion dollars in deals and then some, when you can add in extra deals that could come out of other potential markets from their success. So, again, what is going on with them, outside waiting on the IND, now that the success of the Test from a few weeks ago happened?
This is what I have a hard time comprehending. We heard so much about the deals being put into place and about the testing and now, it's just the IND and nothing on the deals, nothing on the remaining upfront money, nothing on the invoices, nothing on anything else.
Silence.
We haven't heard anything on the invoices being paid by Bintai. That is concerning.
We know they are putting in the IND. That will happen within the next 15 days now.
However, that is for the US FDA. What about the China and Malaysia deals? That is 2.5 billion dollars. Let me type that again, 2.5 billion dollars in deals and then some, when you can add in extra deals that could come out of other potential markets from their success. So, again, what is going on with them, outside waiting on the IND, now that the success of the Test from a few weeks ago happened?
This is what I have a hard time comprehending. We heard so much about the deals being put into place and about the testing and now, it's just the IND and nothing on the deals, nothing on the remaining upfront money, nothing on the invoices, nothing on anything else.
Silence.
(4)
(0)
